News on C.D.U. Limited from BioPortfolio.com http://www.BioPortfolio.com Consolidated C.D.U. Limited news from BioPortfolio.com Wed, 10 Feb 2010 08:19:21 GMT en Relenza royalty for December 2009 quarterhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026975&HITNO=0&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026975&THISHREF=http://c.moreover.com/click/here.pl%3fz2531612992%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026975&HITNO=0&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026975&THISHREF=http://c.moreover.com/click/here.pl%3fz2531612992%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Effect of Graft Selection on the Incidence of Postoperative Infection in Anterior Cruciate Ligament Reconstruchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024622&HITNO=1&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024622&THISHREF=http://c.moreover.com/click/here.pl%3fz2529009091%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024622&HITNO=1&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024622&THISHREF=http://c.moreover.com/click/here.pl%3fz2529009091%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Journal of Sports Medicine: Benitec Limited (ASX:BLT) Licensee Achieves Significant Milestone With Pfizer (NYSE:PFE)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017904&HITNO=2&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017904&THISHREF=http://c.moreover.com/click/here.pl%3fz2525358687%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017904&HITNO=2&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017904&THISHREF=http://c.moreover.com/click/here.pl%3fz2525358687%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: Benitec Limited (ASX:BLT) Licensee Achieves Significant Milestone With Pfizer (NYSE:PFE)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017905&HITNO=3&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017905&THISHREF=http://c.moreover.com/click/here.pl%3fz2525358762%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017905&HITNO=3&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017905&THISHREF=http://c.moreover.com/click/here.pl%3fz2525358762%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: Benitec Limited (ASX:BLT) Licensee Achieves Significant Milestone With Pfizer (NYSE:PFE)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021355&HITNO=4&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021355&THISHREF=http://c.moreover.com/click/here.pl%3fz2527199308%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4021355&HITNO=4&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4021355&THISHREF=http://c.moreover.com/click/here.pl%3fz2527199308%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Benitec Limited (ASX:BLT) Licensee Achieves Significant Milestone With Pfizer (NYSE:PFE)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017941&HITNO=5&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017941&THISHREF=http://c.moreover.com/click/here.pl%3fz2525383804%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4017941&HITNO=5&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4017941&THISHREF=http://c.moreover.com/click/here.pl%3fz2525383804%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! News Australia: Biota Announces Relenza Royalty for December 2009 Quarterhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020611&HITNO=6&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020611&THISHREF=http://c.moreover.com/click/here.pl%3fz2526878032%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4020611&HITNO=6&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4020611&THISHREF=http://c.moreover.com/click/here.pl%3fz2526878032%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Biota Announces Relenza Royalty for December 2009 Quarterhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018648&HITNO=7&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018648&THISHREF=http://c.moreover.com/click/here.pl%3fz2525858069%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018648&HITNO=7&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018648&THISHREF=http://c.moreover.com/click/here.pl%3fz2525858069%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Biota Announces Relenza Royalty for December 2009 Quarter - Zibb....http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018282&HITNO=8&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018282&THISHREF=http://c.moreover.com/click/here.pl%3fz2525554835%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018282&HITNO=8&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018282&THISHREF=http://c.moreover.com/click/here.pl%3fz2525554835%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: Biota Announces Relenza Royalty for December 2009 Quarterhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018276&HITNO=9&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018276&THISHREF=http://c.moreover.com/click/here.pl%3fz2525552914%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018276&HITNO=9&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018276&THISHREF=http://c.moreover.com/click/here.pl%3fz2525552914%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Biota Announces Relenza Royalty for December 2009 Quarterhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018126&HITNO=10&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018126&THISHREF=http://c.moreover.com/click/here.pl%3fz2525488484%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018126&HITNO=10&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018126&THISHREF=http://c.moreover.com/click/here.pl%3fz2525488484%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015286&HITNO=11&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015286&THISHREF=http://c.moreover.com/click/here.pl%3fz2524353311%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015286&HITNO=11&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015286&THISHREF=http://c.moreover.com/click/here.pl%3fz2524353311%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015279&HITNO=12&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015279&THISHREF=http://c.moreover.com/click/here.pl%3fz2524350732%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4015279&HITNO=12&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4015279&THISHREF=http://c.moreover.com/click/here.pl%3fz2524350732%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: A glimpse of future hepatitis C virus treatment paradigms - telaprevirhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994861&HITNO=13&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994861&THISHREF=http://c.moreover.com/click/here.pl%3fz2515320420%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3994861&HITNO=13&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3994861&THISHREF=http://c.moreover.com/click/here.pl%3fz2515320420%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNational AIDS Treatment Advocacy Project: Starpharma and Lilly Sign New Drug Delivery Collaboration for Human Pharmaceuticalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991329&HITNO=14&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991329&THISHREF=http://c.moreover.com/click/here.pl%3fz2513664271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3991329&HITNO=14&MSIZE=63&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=C.D.U.%20Limited&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3991329&THISHREF=http://c.moreover.com/click/here.pl%3fz2513664271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: